{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:30:06Z","timestamp":1790721006143,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"fund project of university of south china for prevention and control of covid-19","award":["2020-22"],"award-info":[{"award-number":["2020-22"]}]},{"name":"the scientific research\u00a0fund\u00a0project\u00a0of\u00a0hunan\u00a0provincial health\u00a0commission","award":["20201983"],"award-info":[{"award-number":["20201983"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11010-021-04269-0","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T14:28:36Z","timestamp":1634308116000},"page":"191-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p\/GRIA3"],"prefix":"10.1007","volume":"477","author":[{"given":"Min-Jie","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-518X","authenticated-orcid":false,"given":"Rong-Juan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"4269_CR1","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS (2016) Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism 65:1109\u20131123. https:\/\/doi.org\/10.1016\/j.metabol.2016.05.003","journal-title":"Metabolism"},{"issue":"7","key":"4269_CR2","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24(7):908\u2013922. https:\/\/doi.org\/10.1038\/s41591-018-0104-9","journal-title":"Nat Med"},{"key":"4269_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM (2019) Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol 70:531\u2013544. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.033","journal-title":"J Hepatol"},{"key":"4269_CR4","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/imj.14709","volume":"50","author":"TD Huang","year":"2020","unstructured":"Huang TD, Behary J, Zekry A (2020) Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management. Intern Med J 50:1038\u20131047. https:\/\/doi.org\/10.1111\/imj.14709","journal-title":"Intern Med J"},{"key":"4269_CR5","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1038\/s41467-018-05383-2","volume":"9","author":"XY Zhao","year":"2018","unstructured":"Zhao XY, Xiong X, Liu T, Mi L, Peng X, Rui C, Guo L, Li S, Li X, Lin JD (2018) Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis. Nat Commun 9:2986. https:\/\/doi.org\/10.1038\/s41467-018-05383-2","journal-title":"Nat Commun"},{"key":"4269_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.trsl.2017.09.001","volume":"190","author":"F Leti","year":"2017","unstructured":"Leti F, Legendre C, Still CD, Chu X, Petrick A, Gerhard GS, DiStefano JK (2017) Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells. Transl Res 190:25\u201339. https:\/\/doi.org\/10.1016\/j.trsl.2017.09.001","journal-title":"Transl Res"},{"key":"4269_CR7","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fphar.2018.00888","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Xu Y, Zhao D, Chen T, Gu C, Yu G, Chen K, Zhong Y, He J, Liu S, Nie Y, Yang H (2018) LncRNA-AK012226 Is involved in fat accumulation in db\/db mice fatty liver and non-alcoholic fatty liver disease cell model. Front Pharmacol 9:888. https:\/\/doi.org\/10.3389\/fphar.2018.00888","journal-title":"Front Pharmacol"},{"key":"4269_CR8","doi-asserted-by":"publisher","first-page":"116829","DOI":"10.1016\/j.lfs.2019.116829","volume":"235","author":"X Chen","year":"2019","unstructured":"Chen X, Tan XR, Li SJ, Zhang XX (2019) LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p\/ROCK1 in nonalcoholic fatty liver disease. Life Sci 235:116829. https:\/\/doi.org\/10.1016\/j.lfs.2019.116829","journal-title":"Life Sci"},{"key":"4269_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.sbi.2018.10.001","volume":"53","author":"S Zhao","year":"2018","unstructured":"Zhao S, Zhang X, Li H (2018) Beyond histone acetylation-writing and erasing histone acylations. Curr Opin Struct Biol 53:169\u2013177. https:\/\/doi.org\/10.1016\/j.sbi.2018.10.001","journal-title":"Curr Opin Struct Biol"},{"key":"4269_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nsmb.2784","volume":"21","author":"E Smith","year":"2014","unstructured":"Smith E, Shilatifard A (2014) Enhancer biology and enhanceropathies. Nat Struct Mol Biol 21:210\u2013219. https:\/\/doi.org\/10.1038\/nsmb.2784","journal-title":"Nat Struct Mol Biol"},{"key":"4269_CR11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/jcb.29427","volume":"121","author":"D Liu","year":"2020","unstructured":"Liu D, Zhang H, Cong J, Cui M, Ma M, Zhang F, Sun H, Chen C (2020) H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163\/YAP1 axis. J Cell Biochem 121:1923\u20131933. https:\/\/doi.org\/10.1002\/jcb.29427","journal-title":"J Cell Biochem"},{"key":"4269_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-018-0931-9","volume":"18","author":"H Dong","year":"2019","unstructured":"Dong H, Hu J, Zou K, Ye M, Chen Y, Wu C, Chen X, Han M (2019) Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Mol Cancer 18:3. https:\/\/doi.org\/10.1186\/s12943-018-0931-9","journal-title":"Mol Cancer"},{"key":"4269_CR13","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.celrep.2018.12.094","volume":"26","author":"N Becares","year":"2019","unstructured":"Becares N, Gage MC, Voisin M, Shrestha E, Martin-Gutierrez L, Liang N, Louie R, Pourcet B, Pello OM, Luong TV, Go\u00f1i S, Pichardo-Almarza C, R\u00f8berg-Larsen H, Diaz-Zuccarini V, Steffensen KR, O\u2019Brien A, Garabedian MJ, Rombouts K, Treuter E, Pineda-Torra I (2019) Impaired LXR\u03b1 phosphorylation attenuates progression of fatty liver disease. Cell Rep 26:984\u2013995. https:\/\/doi.org\/10.1016\/j.celrep.2018.12.094","journal-title":"Cell Rep"},{"key":"4269_CR14","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1038\/s41467-018-05309-y","volume":"9","author":"Y Liu","year":"2018","unstructured":"Liu Y, Jiang L, Sun C, Ireland N, Shah YM, Liu Y, Rui L (2018) Insulin\/Snail1 axis ameliorates fatty liver disease by epigenetically suppressing lipogenesis. Nat Commun 9:2751. https:\/\/doi.org\/10.1038\/s41467-018-05309-y","journal-title":"Nat Commun"},{"key":"4269_CR15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/1873-3468.13384","volume":"593","author":"H Liang","year":"2019","unstructured":"Liang H, Xie X, Song X, Huang M, Su T, Chang X, Liang B, Huang D (2019) Orphan nuclear receptor NR4A1 suppresses hyperhomocysteinemia-induced hepatic steatosis in vitro and in vivo. FEBS Lett 593:1061\u20131071. https:\/\/doi.org\/10.1002\/1873-3468.13384","journal-title":"FEBS Lett"},{"key":"4269_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2217\/epi-2017-0126","volume":"10","author":"K Hrovatin","year":"2018","unstructured":"Hrovatin K, Kunej T (2018) Classification of miRNA-related sequence variations. Epigenomics 10:463\u2013481. https:\/\/doi.org\/10.2217\/epi-2017-0126","journal-title":"Epigenomics"},{"key":"4269_CR17","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","volume":"68","author":"M Gjorgjieva","year":"2019","unstructured":"Gjorgjieva M, Sobolewski C, Dolicka D, Correia de Sousa M, Foti M (2019) miRNAs and NAFLD: from pathophysiology to therapy. Gut 68:2065\u20132079. https:\/\/doi.org\/10.1136\/gutjnl-2018-318146","journal-title":"Gut"},{"key":"4269_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/gutjnl-2016-312869","volume":"67","author":"G Hanin","year":"2018","unstructured":"Hanin G, Yayon N, Tzur Y, Haviv R, Bennett ER, Udi S, Krishnamoorthy YR, Kotsiliti E, Zangen R, Efron B, Tam J, Pappo O, Shteyer E, Pikarsky E, Heikenwalder M, Greenberg DS, Soreq H (2018) miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression. Gut 67:1124\u20131134. https:\/\/doi.org\/10.1136\/gutjnl-2016-312869","journal-title":"Gut"},{"key":"4269_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1530\/jme-16-0179","volume":"59","author":"Y Guo","year":"2017","unstructured":"Guo Y, Yu J, Wang C, Li K, Liu B, Du Y, Xiao F, Chen S, Guo F (2017) miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1. J Mol Endocrinol 59:205\u2013217. https:\/\/doi.org\/10.1530\/jme-16-0179","journal-title":"J Mol Endocrinol"},{"key":"4269_CR20","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.18632\/aging.102201","volume":"11","author":"C Wei","year":"2019","unstructured":"Wei C, Zhang R, Cai Q, Gao X, Tong F, Dong J, Hu Y, Wu G, Dong X (2019) MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer. Aging (Albany NY) 11:6734\u20136761. https:\/\/doi.org\/10.18632\/aging.102201","journal-title":"Aging (Albany NY)"},{"key":"4269_CR21","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G (2015) NAFLD: a multisystem disease. J Hepatol 62:S47\u2013S64. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012","journal-title":"J Hepatol"},{"key":"4269_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24:908\u2013922. https:\/\/doi.org\/10.1038\/s41591-018-0104-9","journal-title":"Nat Med"},{"key":"4269_CR23","doi-asserted-by":"publisher","first-page":"110509","DOI":"10.1016\/j.mce.2019.110509","volume":"495","author":"CS Anyetei-Anum","year":"2019","unstructured":"Anyetei-Anum CS, Evans RM, Back AM, Roggero VR, Allison LA (2019) Acetylation modulates thyroid hormone receptor intracellular localization and intranuclear mobility. Mol Cell Endocrinol 495:110509. https:\/\/doi.org\/10.1016\/j.mce.2019.110509","journal-title":"Mol Cell Endocrinol"},{"key":"4269_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.ccell.2019.04.004","volume":"35","author":"B Krug","year":"2019","unstructured":"Krug B, De Jay N, Harutyunyan AS, Deshmukh S, Marchione DM, Guilhamon P, Bertrand KC, Mikael LG, McConechy MK, Chen CCL, Khazaei S, Koncar RF, Agnihotri S, Faury D, Ellezam B, Weil AG, Ursini-Siegel J, De Carvalho DD, Dirks PB, Lewis PW, Salomoni P, Lupien M, Arrowsmith C, Lasko PF, Garcia BA, Kleinman CL, Jabado N, Mack SC (2019) Pervasive H3K27 acetylation leads to ERV expression and a therapeutic vulnerability in H3K27M gliomas. Cancer Cell 35:782-797.e8. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.004","journal-title":"Cancer Cell"},{"key":"4269_CR25","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1093\/nar\/gkw1247","volume":"45","author":"E Zhang","year":"2017","unstructured":"Zhang E, Han L, Yin D, He X, Hong L, Si X, Qiu M, Xu T, De W, Xu L, Shu Y, Chen J (2017) H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Res 45:3086\u20133101. https:\/\/doi.org\/10.1093\/nar\/gkw1247","journal-title":"Nucleic Acids Res"},{"key":"4269_CR26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bbrc.2019.06.104","volume":"516","author":"Y Sun","year":"2019","unstructured":"Sun Y, Song Y, Liu C, Geng J (2019) LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK\/SREBP-1 signaling. Biochem Biophys Res Commun 516:584\u2013590. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.104","journal-title":"Biochem Biophys Res Commun"},{"key":"4269_CR27","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/jcb.26317","volume":"119","author":"X Wang","year":"2018","unstructured":"Wang X (2018) Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR\/S6K1 signaling pathway. J Cell Biochem 119:1567\u20131574. https:\/\/doi.org\/10.1002\/jcb.26317","journal-title":"J Cell Biochem"},{"key":"4269_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s12885-019-5983-8","volume":"19","author":"RS Zhou","year":"2019","unstructured":"Zhou RS, Zhang EX, Sun QF, Ye ZJ, Liu JW, Zhou DH, Tang Y (2019) Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer 19:779. https:\/\/doi.org\/10.1186\/s12885-019-5983-8","journal-title":"BMC Cancer"},{"key":"4269_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.intimp.2018.03.023","volume":"59","author":"Y Chen","year":"2018","unstructured":"Chen Y, Qiu J, Chen B, Lin Y, Chen Y, Xie G, Qiu J, Tong H, Jiang D (2018) Long non-coding RNA NEAT1 plays an important role in sepsis-induced acute kidney injury by targeting miR-204 and modulating the NF-\u03baB pathway. Int Immunopharmacol 59:252\u2013260. https:\/\/doi.org\/10.1016\/j.intimp.2018.03.023","journal-title":"Int Immunopharmacol"},{"key":"4269_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1530\/jme-18-0098","volume":"61","author":"YH Bai","year":"2018","unstructured":"Bai YH, Lv Y, Wang WQ, Sun GL, Zhang HH (2018) LncRNA NEAT1 promotes inflammatory response and induces corneal neovascularization. J Mol Endocrinol 61:231\u2013239. https:\/\/doi.org\/10.1530\/jme-18-0098","journal-title":"J Mol Endocrinol"},{"key":"4269_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-017-0493-0","volume":"10","author":"CH Wei","year":"2017","unstructured":"Wei CH, Wu G, Cai Q, Gao XC, Tong F, Zhou R, Zhang RG, Dong JH, Hu Y, Dong XR (2017) MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK\/ERK signaling pathway. J Hematol Oncol 10:125. https:\/\/doi.org\/10.1186\/s13045-017-0493-0","journal-title":"J Hematol Oncol"},{"key":"4269_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4103\/1673-5374.232478","volume":"13","author":"Q Liu","year":"2018","unstructured":"Liu Q, Sun NN, Wu ZZ, Fan DH, Cao MQ (2018) Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways. Neural Regen Res 13:837\u2013845. https:\/\/doi.org\/10.4103\/1673-5374.232478","journal-title":"Neural Regen Res"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04269-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04269-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04269-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:06:59Z","timestamp":1744193219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04269-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4269"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04269-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"22 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by The First Affiliated Hospital of University of South China Ethical Committee and all experiments were designed and conveyed following the Declaration of Helsinki. Ten patients with NAFLD and 10 healthy controls from The First Affiliated Hospital of University of South China were enrolled in the present study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not Applicable. This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not Applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}